NIAID Banner Logo Image

Other Viruses Citation List: May 9 - May 22, 2014

Hepatitis B Virus

1. Synthesis, Structure-Activity Relationships and Biological Evaluation of Dehydroandrographolide and Andrographolide Derivatives as Novel anti-Hepatitis B Virus Agents. Chen, H., Y.B. Ma, X.Y. Huang, C.A. Geng, Y. Zhao, L.J. Wang, R.H. Guo, W.J. Liang, X.M. Zhang, and J.J. Chen. Bioorganic & Medicinal Chemistry Letters, 2014. 24(10): p. 2353-2359; PMID[24731274].

[PubMed]. OV_0509-052214.

Hepatitis C Virus

2. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection. Afdhal, N., S. Zeuzem, P. Kwo, M. Chojkier, N. Gitlin, M. Puoti, M. Romero-Gomez, J.P. Zarski, K. Agarwal, P. Buggisch, G.R. Foster, N. Brau, M. Buti, I.M. Jacobson, G.M. Subramanian, X. Ding, H. Mo, J.C. Yang, P.S. Pang, W.T. Symonds, J.G. McHutchison, A.J. Muir, A. Mangia, and P. Marcellin. The New England Journal of Medicine, 2014. 370(20): p. 1889-1898; PMID[24725239].

[PubMed]. OV_0509-052214.


3. MicroRNA-27a Modulates HCV Infection in Differentiated Hepatocyte-like Cells from Adipose Tissue-derived Mesenchymal Stem Cells. Choi, J.E., W. Hur, J.H. Kim, T.Z. Li, E.B. Lee, S.W. Lee, W. Kang, E.C. Shin, T. Wakita, and S.K. Yoon. Plos One, 2014. 9(5): p. e91958; PMID[24824429].

[PubMed]. OV_0509-052214.


4. Design and Synthesis of Spirocyclic Compounds as HCV Replication Inhibitors by Targeting Viral NS4B Protein. Tai, V.W., D. Garrido, D.J. Price, A. Maynard, J.J. Pouliot, Z. Xiong, J.W. Seal, 3rd, K.L. Creech, L.H. Kryn, T.M. Baughman, and A.J. Peat. Bioorganic & Medicinal Chemistry Letters, 2014. 24(10): p. 2288-2294; PMID[24731273].

[PubMed]. OV_0509-052214.


5. Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-acting Antiviral Agents. Xiao, F., I. Fofana, L. Heydmann, H. Barth, E. Soulier, F. Habersetzer, M. Doffoel, J. Bukh, A.H. Patel, M.B. Zeisel, and T.F. Baumert. Plos Pathogens, 2014. 10(5): p. e1004128; PMID[24830295].

[PubMed]. OV_0509-052214.


6. Synthesis and anti-BVDV Activity of Novel delta-Sultones in Vitro: Implications for HCV Therapies. Xu, H.W., L.J. Zhao, H.F. Liu, D. Zhao, J. Luo, X.P. Xie, W.S. Liu, J.X. Zheng, G.F. Dai, H.M. Liu, L.H. Liu, and Y.B. Liang. Bioorganic & Medicinal Chemistry Letters, 2014. 24(10): p. 2388-2391; PMID[24745970].

[PubMed]. OV_0509-052214.

Herpes Simplex Virus 1

7. In Vitro Inhibition of Herpes Simplex Virus Type 1 Replication by Mentha suaveolens Essential Oil and Its Main Component Piperitenone Oxide. Civitelli, L., S. Panella, M.E. Marcocci, A. De Petris, S. Garzoli, F. Pepi, E. Vavala, R. Ragno, L. Nencioni, A.T. Palamara, and L. Angiolella. Phytomedicine, 2014. 21(6): p. 857-865; PMID[24629600].

[PubMed]. OV_0509-052214.

Citations from the ISI Web of Knowledge Listings for O.V.

8. The Chemistry and Biological Potential of Azetidin-2-ones. Arya, N., A.Y. Jagdale, T.A. Patil, S.S. Yeramwar, S.S. Holikatti, J. Dwivedi, C.J. Shishoo, and K.S. Jain. European Journal of Medicinal Chemistry, 2014. 74: p. 619-656; ISI[000333780800054].

[WOS]. OV_0509-052214.


9. Potent Hepatitis C Inhibitors Bind Directly to NS5A and Reduce Its Affinity for RNA. Ascher, D.B., J. Wielens, T.L. Nero, L. Doughty, C.J. Morton, and M.W. Parker. Scientific Reports, 2014. 4: 4765; ISI[000334836500012].

[WOS]. OV_0509-052214.


10. Synthesis and Antiviral Activity of Ethyl 1,2-Dimethyl-5-hydroxy-1H-indole-3-carboxylates and Their Derivatives. Ivashchenko, A.V., P.M. Yamanushkin, O.D. Mit'kin, V.M. Kisil, O.M. Korzinov, V.Y. Vedenskii, I.A. Leneva, E.A. Bulanova, V.V. Bychko, and I.M. Okun. Pharmaceutical Chemistry Journal, 2014. 47(12): p. 636-650; ISI[000334916800002].

[WOS]. OV_0509-052214.


11. Inhibition of HCV Replication by Cyclophilin Antagonists Is Linked to Replication Fitness and Occurs by Inhibition of Membranous Web Formation. Madan, V., D. Paul, V. Lohmann, and R. Bartenschlager. Gastroenterology, 2014. 146(5): p. 1361-1372; ISI[000334507600036].

[WOS]. OV_0509-052214.


12. Protides of N-(3-(5-(2 '-Deoxyuridine))prop-2-ynyl)octanamide as Potential Anti-tubercular and Anti-viral Agents. McGuigan, C., M. Derudas, B. Gonczy, K. Hinsinger, S. Kandil, F. Pertusati, M. Serpi, R. Snoeck, G. Andrei, J. Balzarini, T.D. McHugh, A. Maitra, E. Akorli, D. Evangelopoulos, and S. Bhakta. Bioorganic & Medicinal Chemistry, 2014. 22(9): p. 2816-2824; ISI[000334744100026].

[WOS]. OV_0509-052214.


13. Synthesis and Antiviral Evaluation of 4 '-(1,2,3-Triazol-1-yl)thymidines. Vernekar, S.K.V., L. Qiu, J. Zacharias, R.J. Geraghty, and Z.Q. Wang. MedChemComm, 2014. 5(5): p. 603-608; ISI[000335011900007].

[WOS]. OV_0509-052214.


14. Robust and Persistent Replication of the Genotype 6a Hepatitis C Virus Replicon in Cell Culture. Yu, M., B. Peng, K. Chan, R.Y. Gong, H.L. Yang, W. Delaney, and G.F. Cheng. Antimicrobial Agents and Chemotherapy, 2014. 58(5): p. 2638-2646; ISI[000334364300018].

[WOS]. OV_0509-052214.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021